Legis Daily

COVID–19 Long Haulers Act

USA117th CongressHR-2754| House 
| Updated: 4/23/2021
Donald S. Beyer

Donald S. Beyer

Democratic Representative

Virginia

Cosponsors (3)
Ann M. Kuster (Democratic)Blake D. Moore (Republican)Jack Bergman (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
COVID-19 Long Haulers Act This bill requires multiple agencies to carry out research and other activities concerning individuals experiencing post-acute sequelae of COVID-19, or PASC, including health disparities related to this condition. PASC refers to persistent, long-term symptoms following recovery from acute COVID-19. First, the bill requires the Patient-Centered Outcomes Research Trust Fund to support a patient registry to collect information on the symptoms, treatment, demographics, and other relevant data of COVID-19 patients. Second, the Agency for Healthcare Research and Quality (AHRQ) must conduct or support research on the U.S. health care system's response to long-term symptoms of COVID-19. AHRQ must also develop protocols and guidance to educate medical professionals about PASC diagnostics, treatment, and care. Third, the Centers for Disease Control and Prevention must disseminate information about the common symptoms, treatment options, and disparities that pertain to PASC and related post-infectious illnesses. Last, the Centers for Medicare & Medicaid Services must expand its Chronic Conditions Data Warehouse to collect data on items and services furnished through Medicaid or the Children's Health Insurance Program to individuals who experience PASC.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-9027
COVID–19 Long Haulers Act
Apr 22, 2021
Introduced in House
Apr 22, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 23, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-9027
    COVID–19 Long Haulers Act


  • April 22, 2021
    Introduced in House


  • April 22, 2021
    Referred to the Subcommittee on Health.


  • April 22, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 23, 2021
    Referred to the Subcommittee on Health.

Health

AgingAllergiesCardiovascular and respiratory healthCell biology and embryologyChild healthCongressional oversightDisability and health-based discriminationDisability and paralysisEmergency medical services and trauma careGovernment trust fundsHealth care costs and insuranceHealth care coverage and accessHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesMedicaidMedical researchMedical tests and diagnostic methodsMinority healthNeurological disordersPoverty and welfare assistanceRight of privacyVeterans' medical care

COVID–19 Long Haulers Act

USA117th CongressHR-2754| House 
| Updated: 4/23/2021
COVID-19 Long Haulers Act This bill requires multiple agencies to carry out research and other activities concerning individuals experiencing post-acute sequelae of COVID-19, or PASC, including health disparities related to this condition. PASC refers to persistent, long-term symptoms following recovery from acute COVID-19. First, the bill requires the Patient-Centered Outcomes Research Trust Fund to support a patient registry to collect information on the symptoms, treatment, demographics, and other relevant data of COVID-19 patients. Second, the Agency for Healthcare Research and Quality (AHRQ) must conduct or support research on the U.S. health care system's response to long-term symptoms of COVID-19. AHRQ must also develop protocols and guidance to educate medical professionals about PASC diagnostics, treatment, and care. Third, the Centers for Disease Control and Prevention must disseminate information about the common symptoms, treatment options, and disparities that pertain to PASC and related post-infectious illnesses. Last, the Centers for Medicare & Medicaid Services must expand its Chronic Conditions Data Warehouse to collect data on items and services furnished through Medicaid or the Children's Health Insurance Program to individuals who experience PASC.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-9027
COVID–19 Long Haulers Act
Apr 22, 2021
Introduced in House
Apr 22, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 23, 2021
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 116-9027
    COVID–19 Long Haulers Act


  • April 22, 2021
    Introduced in House


  • April 22, 2021
    Referred to the Subcommittee on Health.


  • April 22, 2021
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • April 23, 2021
    Referred to the Subcommittee on Health.
Donald S. Beyer

Donald S. Beyer

Democratic Representative

Virginia

Cosponsors (3)
Ann M. Kuster (Democratic)Blake D. Moore (Republican)Jack Bergman (Republican)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AgingAllergiesCardiovascular and respiratory healthCell biology and embryologyChild healthCongressional oversightDisability and health-based discriminationDisability and paralysisEmergency medical services and trauma careGovernment trust fundsHealth care costs and insuranceHealth care coverage and accessHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careImmunology and vaccinationInfectious and parasitic diseasesMedicaidMedical researchMedical tests and diagnostic methodsMinority healthNeurological disordersPoverty and welfare assistanceRight of privacyVeterans' medical care